28-Aug-2026
West to Participate in Upcoming Investor Conferences
PRNewswire (Wed, 26-Aug 4:00 PM ET)
West Declares Quarterly Dividend
PRNewswire (Tue, 21-Jul 4:00 PM ET)
West to Host Second-Quarter 2026 Conference Call
PRNewswire (Tue, 7-Jul 6:00 AM ET)
PRNewswire (Wed, 1-Jul 4:30 PM ET)
West Appoints Michel Lagarde to be President and Chief Executive Officer
PRNewswire (Mon, 1-Jun 4:30 PM ET)
West Pharmaceutical Raises 2026 Outlook as High-Value Products Drive Double-Digit Growth
Market Chameleon (Thu, 23-Apr 4:00 AM ET)
WST Raises Guidance After Strong Third Quarter—HVP Components Fuel Double-Digit Growth
Market Chameleon (Thu, 23-Oct 7:56 AM ET)
West Pharmaceutical Lifts 2025 Outlook on Double-Digit HVP Component Growth and Strong Cash Flow
Market Chameleon (Thu, 23-Oct 4:26 AM ET)
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
West Pharmaceutical Servs trades on the NYSE stock market under the symbol WST.
As of August 28, 2026, WST stock price declined to $337.47 with 472,721 million shares trading.
WST has a beta of 0.85, meaning it tends to be less sensitive to market movements. WST has a correlation of 0.10 to the broad based SPY ETF.
WST has a market cap of $23.76 billion. This is considered a Large Cap stock.
Last quarter West Pharmaceutical Servs reported $872 million in Revenue and $2.37 earnings per share. This beat revenue expectation by $34 million and exceeded earnings estimates by $.29.
In the last 3 years, WST traded as high as $415.73 and as low as $187.43.
The top ETF exchange traded funds that WST belongs to (by Net Assets): VTI, VOO, VO, IVV, VUG.
WST has outperformed the market in the last year with a return of +37.8%, while the SPY ETF gained +19.7%. In the last 3 month period, WST beat the market returning +4.9%, while SPY returned +2.2%. However, in the most recent 2 weeks WST has underperformed the stock market by returning -3.4%, while SPY returned -0.9%.
WST support price is $341.07 and resistance is $351.12 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WST shares will trade within this expected range on the day.